2:1 allocation [General Sta­tis­tics]

posted by msmnainar – India, 2021-06-23 18:49 (978 d 01:48 ago) – Posting: # 22428
Views: 1,448

Hi Helmut,

Thanks for your detailed explanation.

❝ ❝ Note: The 2:1 randomization is mainly due to transition arm.


❝ What do you mean by that?


Transition arm is in general re-randomization at certain week after efficacy evaluation (FDA requirement).

Basically, 1:1 randomization allocation would lead to a larger sample size for subjects transitioning from Reference to Test, which would allow for detecting differences in immunogenicity and safety.

Sundar. M

Complete thread:

UA Flag
Activity
 Admin contact
22,912 posts in 4,806 threads, 1,635 registered users;
29 visitors (0 registered, 29 guests [including 5 identified bots]).
Forum time: 19:37 CET (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5